Private equity investment in cardiology continues to generate strong reactions across the specialty. However, the actual footprint of such ownership remains relatively small and is unlikely to become dominant, according to Jerry Blackwell, MD, MBA, FACC, president and CEO at MedAxiom, an ACC company, and a practicing cardiologist at Ballad Health in Kingsport, Tennessee. He presented on private equity at the American College of Cardiology (ACC) 2026 annual meeting and spoke with Cardiovascular Business in the above video interview. Blackwell said concerns about private equity have often outpaced the reality of its actual market presence.
Read the full article: Private Equity Unlikely to Dominate Cardiology Despite Hype //
Source: https://cardiovascularbusiness.com/topics/healthcare-management/medical-practice-management/private-equity-unlikely-dominate-cardiology-despite-hype